All

SumUp and Upvest launch in-app investing for merchants
24 March 2026

SumUp and Upvest launch in-app investing for merchants

SumUp has partnered with Upvest to integrate money market fund investing into its business banking platform for merchants.

Read more
MaaT Pharma Presents the ARES Phase 3 Pivotal Trial Final Data During the Presidential Plenary Session at the 52nd Annual Meeting of the European Society for Bone and Marrow Transplantation
23 March 2026

MaaT Pharma Presents the ARES Phase 3 Pivotal Trial Final Data During the Presidential Plenary Session at the 52nd Annual Meeting of the European Society for Bone and Marrow Transplantation

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated...

Read more
Citalid Secures U.S. Patent for Automated Cyberattack Simulation Powering Its CRQ Platform
17 March 2026

Citalid Secures U.S. Patent for Automated Cyberattack Simulation Powering Its CRQ Platform

Citalid, the leading cyber risk quantification (CRQ) tech provider in Europe, today announced the grant of U.S. Patent No. 12,542,803 B2 for a proprietary automated cyberattack...

Read more
IDnow adopts AI‑powered contact center platform to handle growing IDV volumes
9 March 2026

IDnow adopts AI‑powered contact center platform to handle growing IDV volumes

Identity verification provider IDnow has selected Bright Pattern’s AI‑driven contact center platform to support more than one million video‑based identifications per...

Read more
TransferGo enters new stage of growth: Bank of Lithuania expands company’s EMI license
19 February 2026

TransferGo enters new stage of growth: Bank of Lithuania expands company’s EMI license

The Bank of Lithuania has supplemented the electronic money institution (EMI) license for the fintech company Ltd TransferGo Lithuania. This enhancement enables the company to...

Read more
Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
11 February 2026

Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces positive...

Read more
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
10 February 2026

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

Kainova Therapeutics (“the Company”), a key player for breakthrough treatments for patients in immuno-oncology and inflammation, today announced the successful first close...

Read more
Enterome appoints leading hematologist and IFLI Executive Partner Mehrdad Mobasher, M.D., M.P.H., to its Board of Directors
29 January 2026

Enterome appoints leading hematologist and IFLI Executive Partner Mehrdad Mobasher, M.D., M.P.H., to its Board of Directors

Enterome SA, a clinical-stage company pioneering OncoMimics™, a new class of off-the-shelf, multi-targeted in vivo immune therapies that induce a fast and potent expansion of...

Read more